Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
CONTENTS
Electric Conducting System of Heart Cardiac Action Potential Normal ECG Classificatioln of Arrythmias Pharmacology of Anti-Arrythmic Drugs Newer Drugs Summary
1. SA node
2. AV node
3. Bundle of His
entry)
30 mV 0 mV
Phase 1 Phase 2
Phase 3
Phase 0
Phase 4
P Wave- potential
depolarize before
contraction T wave Potential
generated as the
ventricels recover from the state of
depolarisation.
MECHANISM OF ARRHYTHMIAS
Delayed after- depolarisation is caused by an inward current assocaite with abnormally raised intracellular Ca2+ which triggers ectopic beats. Re- entry is resulting from partial conduction block facilitated when parts of the myocardium are depolarised as a result of diesease. Ectopoic pacemeaker activity which is enocuraged by sympathetic activity. Heart block results from disesae in the conducting system, especially the AV node.
ATRIAL FIBRILATION
Atrial fibrillation is an extremely (400 to 600 atrial beats per minute) and disorganized atrial activation ECG of patient with Atrial fibrillation shows no P waves from the atria or only a fine, high-frequency, very low voltage wavy record. The QRS-T complexes are normal , but their timing is irregular
CLASSIFICATION OF ARRHYTHMIAS
1. Tachy Arrhythmias: a) Supraventricular tachycardia Atrial fibrillation or atrial flutter Paroxymal supraventricular tachycardia Automatic atrial tachycardia b) ventricular arrhymias: premature ventricular complexes(pvcs) ventricular tachycardia torsade depointes ventricular fibrilation 2. Brady arrhythiamas: Sinus brady cardia Heart block
ATRIAL FLUTTER
This arrhythmia is characterized by rapid (270 to 330 atrial beats per minute) but regular atrial activation The slower and regular electrical activity results in a regular ventricular response .
ECG of patient with Atrial flutter shows strong P waves because of contraction of semicoordinate masses of muscle.
PAROXYSMAL TACHYCARDIA
Life-threatening symptoms (syncope, hemodynamic collapse) are associated with extremely rapid rate (e.g., >200 beats per minute) and atrial fibrillation associated with an accessory AV pathway. ECG of PSVT commonly shows a rapid, narrow-QRS-complex tachycardia, regular in rhythm, that starts and stops abruptly. Atrial activity, although present, is difficult to ascertain on surface ECG because P waves are buried within the QRS complex or T wave.
PVCs are very common ventricular rhythm disturbances that occur in patients with or without heart disease. Experimental models have shown that premature ventricular depolarizations may be elicited by abnormal automaticity, triggered activity, or re-entry mechanism. Patients with some forms of PVCs are at higher risk for sudden death than if they did not have these minor rhythm disturbances
VENTRICULAR TACHYCARDIA
Ventricular tachycardia is a wide-QRS-complex tachycardia that may occur acutely as a result of metabolic abnormalities, ischemia, or drug toxicity or recur chronically as a paroxysmal form An acute episode of ventricular tachycardia may be precipitated by severe electrolyte abnormalities (hypokalemia), hypoxemia, digitalis toxicity or heart failure. On ECG inspection, ventricular tachycardia may appear as either repetitive monomorphic or polymorphic ventricular complexes.
TORSADE DE POINTES
It is a rapid form of polymorphic ventricular tachycardia that is associated with evidence of delayed ventricular repolarization (long QT interval or prominent U waves) on surface ECGs Acquired forms of TdP are associated with electrolyte disturbances , subarachnoid hemorrhage, myocarditis, liquid protein diets, arsenic poisoning, hypothyroidism, or most commonly, drug therapy.
VENTRICULAR FIBRILLATION
By definition, VF results in hemodynamic collapse, syncope, and cardiac arrest. Ventricular fibrillation is electrical anarchy of the ventricle resulting in no cardiac output and cardiovascular collapse
SINUS BRADYCARDIA
Sinus bradyarrhythmias (heart rate <60 beats per minute) is a common finding, especially in young, athletically active individuals. Thus the patient may experience paroxysmal episodes of dizziness or syncope because of sinus arrest
ATRIOVENTRICULAR BLOCK
AV block usually is categorized into three different types based on surface ECG findings. First-degree AV block is 1:1AVconduction with a prolonged PR interval. Second-degree AV block is divided into two forms: Mobitz I AV block (Wenkebach periodicity) is less than 1:1 AV conduction with progressively lengthening PR intervals Mobitz II AV block is intermittently dropped ventricular beats in a random fashion without progressive PR-interval Third-degree AV block is complete heart block where AV conduction is totally absent (AV dissociation).
Class II: -adrenoceptor antagonists (atenolol, sotalol) Class III: prolong action potential and prolong refractory period (suppress re-entrant rhythms) (amiodarone, sotalol) Class IV: Calcium channel blockers. Impair impulse propagation in nodal and damaged areas (verapamil, Diltiazem)
IV
0 mV Phase 0 Phase 2
III
-80mV
Phase 4
II
Lengthen action potential Slow rate of rise of phase 0 Prolong repolarization Prolong refractoriness by blocking several types of potassium channel
Inhibition of Na channel slanted O phase and Decreases phase 4 Net result is delay in conductivity and increase in refractoriness Other actions include alpha blockade, decreased skeletal muscle contractility, vomiting and diarrhoea etc
Broad spectrum antiarrhythmic Atrial fibrillation and flutter, AF after direct current cardioversion to maintain sinus rhythm, prevention of PSVT and prevention of VT
Adverse effects: Proarrhythmia (torsades de pointes), sudden cardiac arrest, cinchonism etc.
PROCAINAMIDE
Minimal antivagal action Lesser suppression of ectopic automaticity Lesser depression of automaticity and AV conduction No alpha blocking action
Kinetics:
Absorbed orally and bioavailability is 80% Metabolized in liver to N-acetyl-procainamide (NAPA) blocks K channel and
prolongs repolarization
Dosage 250 mg tabs and 1gm/ml injections
CLASS II
They act indirectly on Electrophysiology by blocking beta-adrenergic receptor, prolong PR interval, but no effects on QRS or QT interval
Blocks AV conduction
Uses:
Reduce mortality after MI Arrhythmias associated with increased sympathetic activity sinus tachycardia, atrial extrasystoles provoked by emotion and exercise
CLASS III
Class III drugs K channel blockers prolong repolarization (increase refractoriness) by blocking outward potassium conductance Prolongation of Cardiac action potential Also have interaction with the ANS Diverse Pharmacology which is poorly understood
Drugs Ibutilide, dofetilide, sotalol (II + III action), amiodarone and bretylium Bretylium is used only in life threatening arrhythmias
AMIODARONE
MOA: Long acting and highly lipophillic Weak class I, II (beta- blocker) and class IV actions Depresses automaticity of SA and AVN Also non-competitive alpha and beta blocking property Also direct coronray and peripheral vasodiltor Kinetics: Incompletely and slowly absorbed daily oral dose is give for several days for actions tto develop, t1/2 = 3-8 weeks Dose: 400-600 mg/day p.o for many days followed by 100-200 mg/day as maintenance (100-300 mg slow IV)
AMIODARONE
Uses: Most tachyarrhythmic conditions ventricular and supraventricular
Recurrent VT and VF
WPW syndrome Adverse effects: Photosensitization Peripheral neuropathy Myocardial depression bradycardia Pulmonary alveolitis and fibrosis Cornel micro deposits hypothyroidism
CLASS IV
Relatively selective AV nodal L-type calcium channel blockers slow sinus rhythm, prolong PR interval, no effect on QRS complex Negative ionotropic effect interference with Ca++ mediated contraction
MOA: Block L-type channels Phase 4 depolarization of SA and PF reduced Reduce slow inward current and force of contraction Also slow conduction of AV node due to calcium channel blockade
CLASS IV
ADR :
NEWER DRUGS
Dronedarone: It is a benzofuran derivative of amiodarone. It acts by blocking K+ currents. Tecadenoson: It is an Adenosine receptor blocker. It terminates PSVT Tedlisamil: Blockade of multiple K+ channels. It lengthens monophasic Action Potential and Refractory Period Azimilide: Exerts its effects by blocking K+ currents
SUMMARY
Anti-arrhythmic drugs are classified by their effect on the cardiac action potential An ideal antiarrhythmic drug should target ectopic pacemakers and rapidly depolarizing tissues to a greater extent than normal tissues of the heart Many of the Na and Ca channel blockers have this property because they preferentially block sodium and calcium channels in the depolarized tissues Most of the drugs exhibit mixed action In clinical practice treatment of arrhythmias is determined by the type of arrhythmia (SVT, VT) and clinical condition of the patient Anti-arrhythmic drugs are efficacious but may have serious adverse effects Not all arrhythmias are treated with drug therapy alone
THANK YOU